Triple artemisinin-based combination therapies for malaria – a new paradigm?

Recent gains in the fight against malaria are threatened by the emergence and spread of artemisinin and partner drug resistance in Plasmodium falciparum in the Greater Mekong Subregion (GMS). When artemisinins are combined with a single partner drug, all recommended artemisinin-based combination the...

Full description

Bibliographic Details
Main Authors: van der Pluijm, RW, Amaratunga, C, Dhorda, M, Dondorp, AM
Format: Journal article
Language:English
Published: Elsevier 2020
_version_ 1797075702662561792
author van der Pluijm, RW
Amaratunga, C
Dhorda, M
Dondorp, AM
author_facet van der Pluijm, RW
Amaratunga, C
Dhorda, M
Dondorp, AM
author_sort van der Pluijm, RW
collection OXFORD
description Recent gains in the fight against malaria are threatened by the emergence and spread of artemisinin and partner drug resistance in Plasmodium falciparum in the Greater Mekong Subregion (GMS). When artemisinins are combined with a single partner drug, all recommended artemisinin-based combination therapies have shown reduced efficacy in some countries in the GMS at some point. Novel drugs are not available for the near future. Triple artemisinin-based combination therapies, combining artemisinins with two currently available partner drugs, will provide one of the last remaining safe and effective treatments for falciparum malaria that can be deployed rapidly in the GMS, whereas their deployment beyond the GMS could delay or prevent the global emergence and spread of resistance to currently available drugs.
first_indexed 2024-03-06T23:54:00Z
format Journal article
id oxford-uuid:73964964-3db5-47a2-b2aa-a8df4a57548e
institution University of Oxford
language English
last_indexed 2024-03-06T23:54:00Z
publishDate 2020
publisher Elsevier
record_format dspace
spelling oxford-uuid:73964964-3db5-47a2-b2aa-a8df4a57548e2022-03-26T19:57:21ZTriple artemisinin-based combination therapies for malaria – a new paradigm?Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:73964964-3db5-47a2-b2aa-a8df4a57548eEnglishSymplectic ElementsElsevier2020van der Pluijm, RWAmaratunga, CDhorda, MDondorp, AMRecent gains in the fight against malaria are threatened by the emergence and spread of artemisinin and partner drug resistance in Plasmodium falciparum in the Greater Mekong Subregion (GMS). When artemisinins are combined with a single partner drug, all recommended artemisinin-based combination therapies have shown reduced efficacy in some countries in the GMS at some point. Novel drugs are not available for the near future. Triple artemisinin-based combination therapies, combining artemisinins with two currently available partner drugs, will provide one of the last remaining safe and effective treatments for falciparum malaria that can be deployed rapidly in the GMS, whereas their deployment beyond the GMS could delay or prevent the global emergence and spread of resistance to currently available drugs.
spellingShingle van der Pluijm, RW
Amaratunga, C
Dhorda, M
Dondorp, AM
Triple artemisinin-based combination therapies for malaria – a new paradigm?
title Triple artemisinin-based combination therapies for malaria – a new paradigm?
title_full Triple artemisinin-based combination therapies for malaria – a new paradigm?
title_fullStr Triple artemisinin-based combination therapies for malaria – a new paradigm?
title_full_unstemmed Triple artemisinin-based combination therapies for malaria – a new paradigm?
title_short Triple artemisinin-based combination therapies for malaria – a new paradigm?
title_sort triple artemisinin based combination therapies for malaria a new paradigm
work_keys_str_mv AT vanderpluijmrw tripleartemisininbasedcombinationtherapiesformalariaanewparadigm
AT amaratungac tripleartemisininbasedcombinationtherapiesformalariaanewparadigm
AT dhordam tripleartemisininbasedcombinationtherapiesformalariaanewparadigm
AT dondorpam tripleartemisininbasedcombinationtherapiesformalariaanewparadigm